Kennedy Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-728,490
| Closed | -$13.2M | – | 723 |
|
|
2024
Q3 | $13.2M | Sell |
728,490
-102,416
| -12% | -$1.85M | 0.29% | 92 |
|
|
2024
Q2 | $8.56M | Buy |
830,906
+258,570
| +45% | +$2.66M | 0.18% | 187 |
|
|
2024
Q1 | $6.08M | Buy |
572,336
+360
| +0.1% | +$3.82K | 0.13% | 274 |
|
|
2023
Q4 | $5.22M | Sell |
571,976
-489,769
| -46% | -$4.47M | 0.11% | 298 |
|
|
2023
Q3 | $11M | Buy |
1,061,745
+12,070
| +1% | +$125K | 0.27% | 106 |
|
|
2023
Q2 | $15M | Buy |
+1,049,675
| New | +$15M | 0.35% | 72 |
|